Related Experiment Video
Updated: Apr 18, 2026

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
Published on: June 29, 2014
Steps forward in regulatory pathways for acute and chronic heart failure
Luca Pani1, Sergio Pecorelli, Giuseppe Rosano
1Italian Medicines Agency-AIFA, Rome, Italy.
This workshop focused on heart failure medicine development, emphasizing patient needs and multidisciplinary approaches for effective treatments. Further research is needed for consensus on endpoints and integrating health technology assessment for real-world effectiveness.
Area of Science:
- Cardiology
- Pharmacology
- Health Services Research
Background:
- Heart failure medicine development faces challenges in addressing unmet needs.
- Current approaches may not fully integrate patient perspectives or real-world effectiveness.
Purpose of the Study:
- To discuss unmet needs and future directions in heart failure medicine development.
- To advocate for an integrated, multidisciplinary approach including patient perspectives.
- To explore the integration of health technology assessment and payer perspectives.
Main Methods:
- A workshop organized by the Agenzia Italiana del Farmaco (AIFA).
- Discussion among stakeholders on unmet needs and strategies for heart failure treatments.
- Focus on multidisciplinary approaches and patient-centered care.
Main Results:
- An integrated, multidisciplinary approach, incorporating patient needs, was identified as crucial for effective treatment regimens.
- The need for consensus on clinical and functional endpoints and validation of patient-reported outcomes was highlighted.
- Integrating health technology assessment and payer perspectives, including real-life effectiveness, is essential.
Conclusions:
- A shift from a molecule-centric to a holistic healthcare regimen approach is needed for medicine development and authorization.
- AIFA aims to establish a template for stakeholder meetings to define road maps for addressing unmet needs in heart failure.
- Further work is required to achieve consensus on endpoints and integrate diverse perspectives into clinical programs.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management
Heart Failure I: Introduction
Heart Failure Drugs: β-Blockers